The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom ...

Abbott medical device leader Lisa Earnhardt says her group wants fewer suppliers — but to make them into long-term partners.

Abbott’s ABT diversified business portfolio is well-positioned to drive continued momentum in 2024. Yet, the business ...

We recently compiled a list of the 10 Oversold Healthcare Stocks To Invest In. In this article, we are going to take a look ...

That’s why we recently expanded our manufacturing capacity with the launch of a new 323,000-square-foot site to produce sensors for FreeStyle Libre 3, the latest generation in our world-leading ...

Medicare considers designated blood glucose monitoring systems, such as FreeStyle Libre, to be durable medical equipment ... also have to pay for replacement sensors. Costs for FreeStyle Libre ...

DUBLIN, Ireland: Abbott has launched a state-of-the-art manufacturing facility in Kilkenny, marking a significant milestone in its global diabetes care business. The site, spanning 30,000 square ...

About Insulet Corporation: Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device ... The sensor housing, FreeStyle, Libre, and related brand marks ...

The new 30,000-square meter Kilkenny facility is producing FreeStyle Libre 3 sensors, the world’s smallest sensors and latest generation ... with leading businesses and products in diagnostics, ...

The new 30,000-square meter Kilkenny facility is producing FreeStyle Libre 3 sensors, the world’s smallest1 sensors and latest generation ... with leading businesses and products in diagnostics, ...